Actelion reports higher sales, earnings

Country

Switzerland

Switzerland’s Actelion Ltd, which has a portfolio of treatments for pulmonary arterial hypertension (PAH), reported significantly higher sales and earnings for the third quarter and the first nine months of 2014.